Spectrum Pharmaceuticals reported $140M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Actinium Pharmaceuticals ATNM:US $ 83.26M 90K
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amgen AMGN:US $ 24380M 5281M
Arrowhead Research ARWR:US $ 384.6M 141.36M
Astellas Pharma 4503:JP Y 876454M 7739M
AstraZeneca AZN:LN 26.69B 583M
Bayer BAYN:GR 31.94B 506M
Biogen BIIB:US $ 7162.3M 21.4M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Coherus Biosciences CHRS:US $ 673.04M 13.03M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Endo International Ordinary Shares ENDP:US $ 2748.95M 179.62M
GlaxoSmithKline GSK:LN 18.25B 688M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Novartis NOVN:VX 26.25B 2.45B
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Spectrum Pharmaceuticals SPPI:US $ 140M 25.71M
Takeda 4502:JP Y 2456353M 20105M
Teva Pharmaceutical TEVA:IT 12.15B 668M
YTE INCY:US $ 2923.8M 303.74M